Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT02437032
Clinical Trials · NCT02437032
Gonadotropin Type in Ovarian Stimulation
Completed
Phase 4
Gonadorelin
(Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
IVI Madrid
Enrollment
100
Start date
Apr 2009
Locations
See registry
Primary endpoint
GDF-9 and BMP-15 secretion
View Gonadorelin compound reference